id	sid	tid	token	lemma	pos
cord-294360-1oymweb0	1	1	key	key	JJ
cord-294360-1oymweb0	1	2	:	:	:
cord-294360-1oymweb0	1	3	cord-294360	cord-294360	NN
cord-294360-1oymweb0	1	4	-	-	HYPH
cord-294360-1oymweb0	1	5	1oymweb0	1oymweb0	CD
cord-294360-1oymweb0	1	6	authors	author	NNS
cord-294360-1oymweb0	1	7	:	:	:
cord-294360-1oymweb0	1	8	Mair	Mair	NNP
cord-294360-1oymweb0	1	9	,	,	,
cord-294360-1oymweb0	1	10	Frances	Frances	NNP
cord-294360-1oymweb0	1	11	S	S	NNP
cord-294360-1oymweb0	1	12	;	;	:
cord-294360-1oymweb0	1	13	Foster	Foster	NNP
cord-294360-1oymweb0	1	14	,	,	,
cord-294360-1oymweb0	1	15	Hamish	Hamish	NNP
cord-294360-1oymweb0	1	16	ME	ME	NNP
cord-294360-1oymweb0	1	17	;	;	:
cord-294360-1oymweb0	1	18	Nicholl	Nicholl	NNP
cord-294360-1oymweb0	1	19	,	,	,
cord-294360-1oymweb0	1	20	Barbara	Barbara	NNP
cord-294360-1oymweb0	1	21	I	i	CD
cord-294360-1oymweb0	2	1	title	title	NN
cord-294360-1oymweb0	2	2	:	:	:
cord-294360-1oymweb0	3	1	Multimorbidity	Multimorbidity	NNP
cord-294360-1oymweb0	3	2	and	and	CC
cord-294360-1oymweb0	3	3	the	the	DT
cord-294360-1oymweb0	3	4	COVID-19	covid-19	JJ
cord-294360-1oymweb0	3	5	pandemic	pandemic	NN
cord-294360-1oymweb0	3	6	–	–	:
cord-294360-1oymweb0	3	7	An	an	DT
cord-294360-1oymweb0	3	8	urgent	urgent	JJ
cord-294360-1oymweb0	3	9	call	call	NN
cord-294360-1oymweb0	3	10	to	to	IN
cord-294360-1oymweb0	3	11	action	action	NN
cord-294360-1oymweb0	3	12	date	date	NN
cord-294360-1oymweb0	3	13	:	:	:
cord-294360-1oymweb0	3	14	2020	2020	CD
cord-294360-1oymweb0	3	15	-	-	SYM
cord-294360-1oymweb0	3	16	10	10	CD
cord-294360-1oymweb0	3	17	-	-	SYM
cord-294360-1oymweb0	3	18	13	13	CD
cord-294360-1oymweb0	3	19	journal	journal	NN
cord-294360-1oymweb0	3	20	:	:	:
cord-294360-1oymweb0	3	21	J	J	NNP
cord-294360-1oymweb0	3	22	Comorb	Comorb	NNP
cord-294360-1oymweb0	3	23	DOI	DOI	NNP
cord-294360-1oymweb0	3	24	:	:	:
cord-294360-1oymweb0	4	1	10.1177/2235042x20961676	10.1177/2235042x20961676	NNP
cord-294360-1oymweb0	4	2	sha	sha	NNP
cord-294360-1oymweb0	4	3	:	:	:
cord-294360-1oymweb0	5	1	46714c8fa824467e7ee61d1514e9635cfe02f808	46714c8fa824467e7ee61d1514e9635cfe02f808	CD
cord-294360-1oymweb0	5	2	doc_id	doc_id	CD
cord-294360-1oymweb0	5	3	:	:	:
cord-294360-1oymweb0	6	1	294360	294360	CD
cord-294360-1oymweb0	6	2	cord_uid	cord_uid	FW
cord-294360-1oymweb0	6	3	:	:	:
cord-294360-1oymweb0	7	1	1oymweb0	1oymweb0	CD
cord-294360-1oymweb0	7	2	nan	nan	NNP
cord-294360-1oymweb0	8	1	The	the	DT
cord-294360-1oymweb0	8	2	SARS	SARS	NNP
cord-294360-1oymweb0	8	3	-	-	HYPH
cord-294360-1oymweb0	8	4	CoV-2	CoV-2	NNP
cord-294360-1oymweb0	8	5	virus	virus	NN
cord-294360-1oymweb0	8	6	has	have	VBZ
cord-294360-1oymweb0	8	7	infected	infect	VBN
cord-294360-1oymweb0	8	8	over	over	IN
cord-294360-1oymweb0	8	9	21	21	CD
cord-294360-1oymweb0	8	10	million	million	CD
cord-294360-1oymweb0	8	11	people	people	NNS
cord-294360-1oymweb0	8	12	globally	globally	RB
cord-294360-1oymweb0	8	13	and	and	CC
cord-294360-1oymweb0	8	14	its	-PRON-	PRP$
cord-294360-1oymweb0	8	15	disease	disease	NN
cord-294360-1oymweb0	8	16	,	,	,
cord-294360-1oymweb0	8	17	COVID-19	COVID-19	NNP
cord-294360-1oymweb0	8	18	,	,	,
cord-294360-1oymweb0	8	19	is	be	VBZ
cord-294360-1oymweb0	8	20	responsible	responsible	JJ
cord-294360-1oymweb0	8	21	for	for	IN
cord-294360-1oymweb0	8	22	more	more	JJR
cord-294360-1oymweb0	8	23	than	than	IN
cord-294360-1oymweb0	8	24	770,000	770,000	CD
cord-294360-1oymweb0	8	25	deaths	death	NNS
cord-294360-1oymweb0	8	26	.	.	.
cord-294360-1oymweb0	9	1	1	1	LS
cord-294360-1oymweb0	10	1	Since	since	IN
cord-294360-1oymweb0	10	2	discovery	discovery	NN
cord-294360-1oymweb0	10	3	,	,	,
cord-294360-1oymweb0	10	4	researchers	researcher	NNS
cord-294360-1oymweb0	10	5	and	and	CC
cord-294360-1oymweb0	10	6	clinicians	clinician	NNS
cord-294360-1oymweb0	10	7	across	across	IN
cord-294360-1oymweb0	10	8	the	the	DT
cord-294360-1oymweb0	10	9	world	world	NN
cord-294360-1oymweb0	10	10	have	have	VBP
cord-294360-1oymweb0	10	11	raced	race	VBN
cord-294360-1oymweb0	10	12	to	to	TO
cord-294360-1oymweb0	10	13	understand	understand	VB
cord-294360-1oymweb0	10	14	how	how	WRB
cord-294360-1oymweb0	10	15	COVID-19	covid-19	JJ
cord-294360-1oymweb0	10	16	spreads	spread	NNS
cord-294360-1oymweb0	10	17	,	,	,
cord-294360-1oymweb0	10	18	who	who	WP
cord-294360-1oymweb0	10	19	is	be	VBZ
cord-294360-1oymweb0	10	20	most	most	JJS
cord-294360-1oymweb0	10	21	at	at	IN
cord-294360-1oymweb0	10	22	risk	risk	NN
cord-294360-1oymweb0	10	23	,	,	,
cord-294360-1oymweb0	10	24	and	and	CC
cord-294360-1oymweb0	10	25	how	how	WRB
cord-294360-1oymweb0	10	26	best	good	JJS
cord-294360-1oymweb0	10	27	to	to	TO
cord-294360-1oymweb0	10	28	diagnose	diagnose	VB
cord-294360-1oymweb0	10	29	and	and	CC
cord-294360-1oymweb0	10	30	treat	treat	VB
cord-294360-1oymweb0	10	31	those	those	DT
cord-294360-1oymweb0	10	32	infected	infect	VBN
cord-294360-1oymweb0	10	33	.	.	.
cord-294360-1oymweb0	11	1	Others	other	NNS
cord-294360-1oymweb0	11	2	have	have	VBP
cord-294360-1oymweb0	11	3	been	be	VBN
cord-294360-1oymweb0	11	4	developing	develop	VBG
cord-294360-1oymweb0	11	5	vaccines	vaccine	NNS
cord-294360-1oymweb0	11	6	at	at	IN
cord-294360-1oymweb0	11	7	an	an	DT
cord-294360-1oymweb0	11	8	unprecedented	unprecedented	JJ
cord-294360-1oymweb0	11	9	pace	pace	NN
cord-294360-1oymweb0	11	10	.	.	.
cord-294360-1oymweb0	12	1	Meanwhile	meanwhile	RB
cord-294360-1oymweb0	12	2	,	,	,
cord-294360-1oymweb0	12	3	policymakers	policymaker	NNS
cord-294360-1oymweb0	12	4	have	have	VBP
cord-294360-1oymweb0	12	5	focused	focus	VBN
cord-294360-1oymweb0	12	6	on	on	IN
cord-294360-1oymweb0	12	7	the	the	DT
cord-294360-1oymweb0	12	8	difficult	difficult	JJ
cord-294360-1oymweb0	12	9	balancing	balancing	NN
cord-294360-1oymweb0	12	10	act	act	NN
cord-294360-1oymweb0	12	11	of	of	IN
cord-294360-1oymweb0	12	12	preserving	preserve	VBG
cord-294360-1oymweb0	12	13	crashing	crash	VBG
cord-294360-1oymweb0	12	14	economies	economy	NNS
cord-294360-1oymweb0	12	15	,	,	,
cord-294360-1oymweb0	12	16	enabling	enable	VBG
cord-294360-1oymweb0	12	17	children	child	NNS
cord-294360-1oymweb0	12	18	to	to	TO
cord-294360-1oymweb0	12	19	attend	attend	VB
cord-294360-1oymweb0	12	20	school	school	NN
cord-294360-1oymweb0	12	21	,	,	,
cord-294360-1oymweb0	12	22	and	and	CC
cord-294360-1oymweb0	12	23	people	people	NNS
cord-294360-1oymweb0	12	24	to	to	TO
cord-294360-1oymweb0	12	25	work	work	VB
cord-294360-1oymweb0	12	26	while	while	IN
cord-294360-1oymweb0	12	27	simultaneously	simultaneously	RB
cord-294360-1oymweb0	12	28	trying	try	VBG
cord-294360-1oymweb0	12	29	to	to	TO
cord-294360-1oymweb0	12	30	control	control	VB
cord-294360-1oymweb0	12	31	the	the	DT
cord-294360-1oymweb0	12	32	spread	spread	NN
cord-294360-1oymweb0	12	33	of	of	IN
cord-294360-1oymweb0	12	34	COVID-19	covid-19	NN
cord-294360-1oymweb0	12	35	.	.	.
cord-294360-1oymweb0	13	1	A	a	DT
cord-294360-1oymweb0	13	2	great	great	JJ
cord-294360-1oymweb0	13	3	deal	deal	NN
cord-294360-1oymweb0	13	4	has	have	VBZ
cord-294360-1oymweb0	13	5	been	be	VBN
cord-294360-1oymweb0	13	6	learnt	learn	VBN
cord-294360-1oymweb0	13	7	about	about	IN
cord-294360-1oymweb0	13	8	who	who	WP
cord-294360-1oymweb0	13	9	is	be	VBZ
cord-294360-1oymweb0	13	10	at	at	IN
cord-294360-1oymweb0	13	11	higher	high	JJR
cord-294360-1oymweb0	13	12	risk	risk	NN
cord-294360-1oymweb0	13	13	from	from	IN
cord-294360-1oymweb0	13	14	COVID-19	COVID-19	NNP
cord-294360-1oymweb0	13	15	.	.	.
cord-294360-1oymweb0	14	1	It	-PRON-	PRP
cord-294360-1oymweb0	14	2	is	be	VBZ
cord-294360-1oymweb0	14	3	now	now	RB
cord-294360-1oymweb0	14	4	recognised	recognise	VBN
cord-294360-1oymweb0	14	5	that	that	IN
cord-294360-1oymweb0	14	6	those	those	DT
cord-294360-1oymweb0	14	7	from	from	IN
cord-294360-1oymweb0	14	8	minority	minority	NN
cord-294360-1oymweb0	14	9	ethnic	ethnic	JJ
cord-294360-1oymweb0	14	10	or	or	CC
cord-294360-1oymweb0	14	11	socioeconomically	socioeconomically	RB
cord-294360-1oymweb0	14	12	deprived	deprived	JJ
cord-294360-1oymweb0	14	13	backgrounds	background	NNS
cord-294360-1oymweb0	14	14	and	and	CC
cord-294360-1oymweb0	14	15	those	those	DT
cord-294360-1oymweb0	14	16	with	with	IN
cord-294360-1oymweb0	14	17	specific	specific	JJ
cord-294360-1oymweb0	14	18	long	long	JJ
cord-294360-1oymweb0	14	19	-	-	HYPH
cord-294360-1oymweb0	14	20	term	term	NN
cord-294360-1oymweb0	14	21	conditions	condition	NNS
cord-294360-1oymweb0	14	22	(	(	-LRB-
cord-294360-1oymweb0	14	23	LTCs	LTCs	NNP
cord-294360-1oymweb0	14	24	)	)	-RRB-
cord-294360-1oymweb0	14	25	,	,	,
cord-294360-1oymweb0	14	26	such	such	JJ
cord-294360-1oymweb0	14	27	as	as	IN
cord-294360-1oymweb0	14	28	diabetes	diabetes	NN
cord-294360-1oymweb0	14	29	,	,	,
cord-294360-1oymweb0	14	30	are	be	VBP
cord-294360-1oymweb0	14	31	likely	likely	JJ
cord-294360-1oymweb0	14	32	to	to	TO
cord-294360-1oymweb0	14	33	have	have	VB
cord-294360-1oymweb0	14	34	worse	bad	JJR
cord-294360-1oymweb0	14	35	COVID-19	covid-19	JJ
cord-294360-1oymweb0	14	36	outcomes	outcome	NNS
cord-294360-1oymweb0	14	37	.	.	.
cord-294360-1oymweb0	15	1	2	2	LS
cord-294360-1oymweb0	16	1	However	however	RB
cord-294360-1oymweb0	16	2	,	,	,
cord-294360-1oymweb0	16	3	despite	despite	IN
cord-294360-1oymweb0	16	4	the	the	DT
cord-294360-1oymweb0	16	5	rising	rise	VBG
cord-294360-1oymweb0	16	6	global	global	JJ
cord-294360-1oymweb0	16	7	prevalence	prevalence	NN
cord-294360-1oymweb0	16	8	of	of	IN
cord-294360-1oymweb0	16	9	multimorbidity	multimorbidity	NN
cord-294360-1oymweb0	16	10	(	(	-LRB-
cord-294360-1oymweb0	16	11	the	the	DT
cord-294360-1oymweb0	16	12	presence	presence	NN
cord-294360-1oymweb0	16	13	of	of	IN
cord-294360-1oymweb0	16	14	2	2	CD
cord-294360-1oymweb0	16	15	LTCs	LTCs	NNP
cord-294360-1oymweb0	16	16	)	)	-RRB-
cord-294360-1oymweb0	16	17	,	,	,
cord-294360-1oymweb0	16	18	research	research	NN
cord-294360-1oymweb0	16	19	on	on	IN
cord-294360-1oymweb0	16	20	the	the	DT
cord-294360-1oymweb0	16	21	implications	implication	NNS
cord-294360-1oymweb0	16	22	of	of	IN
cord-294360-1oymweb0	16	23	COVID-19	covid-19	NN
cord-294360-1oymweb0	16	24	for	for	IN
cord-294360-1oymweb0	16	25	those	those	DT
cord-294360-1oymweb0	16	26	with	with	IN
cord-294360-1oymweb0	16	27	multimorbidity	multimorbidity	NN
cord-294360-1oymweb0	16	28	is	be	VBZ
cord-294360-1oymweb0	16	29	sparse	sparse	JJ
cord-294360-1oymweb0	16	30	.	.	.
cord-294360-1oymweb0	17	1	Subsequently	subsequently	RB
cord-294360-1oymweb0	17	2	,	,	,
cord-294360-1oymweb0	17	3	there	there	EX
cord-294360-1oymweb0	17	4	is	be	VBZ
cord-294360-1oymweb0	17	5	no	no	DT
cord-294360-1oymweb0	17	6	public	public	JJ
cord-294360-1oymweb0	17	7	health	health	NN
cord-294360-1oymweb0	17	8	advice	advice	NN
cord-294360-1oymweb0	17	9	tailored	tailor	VBN
cord-294360-1oymweb0	17	10	to	to	IN
cord-294360-1oymweb0	17	11	this	this	DT
cord-294360-1oymweb0	17	12	growing	grow	VBG
cord-294360-1oymweb0	17	13	proportion	proportion	NN
cord-294360-1oymweb0	17	14	of	of	IN
cord-294360-1oymweb0	17	15	the	the	DT
cord-294360-1oymweb0	17	16	world	world	NN
cord-294360-1oymweb0	17	17	's	's	POS
cord-294360-1oymweb0	17	18	population	population	NN
cord-294360-1oymweb0	17	19	.	.	.
cord-294360-1oymweb0	18	1	Multimorbidity	Multimorbidity	NNP
cord-294360-1oymweb0	18	2	is	be	VBZ
cord-294360-1oymweb0	18	3	strongly	strongly	RB
cord-294360-1oymweb0	18	4	associated	associate	VBN
cord-294360-1oymweb0	18	5	with	with	IN
cord-294360-1oymweb0	18	6	mortality	mortality	NN
cord-294360-1oymweb0	18	7	in	in	IN
cord-294360-1oymweb0	18	8	those	those	DT
cord-294360-1oymweb0	18	9	with	with	IN
cord-294360-1oymweb0	18	10	COVID-19	COVID-19	NNP
cord-294360-1oymweb0	18	11	.	.	.
cord-294360-1oymweb0	19	1	3	3	LS
cord-294360-1oymweb0	19	2	Deaths	death	NNS
cord-294360-1oymweb0	19	3	from	from	IN
cord-294360-1oymweb0	19	4	COVID-19	COVID-19	NNP
cord-294360-1oymweb0	19	5	are	be	VBP
cord-294360-1oymweb0	19	6	a	a	DT
cord-294360-1oymweb0	19	7	source	source	NN
cord-294360-1oymweb0	19	8	of	of	IN
cord-294360-1oymweb0	19	9	a	a	DT
cord-294360-1oymweb0	19	10	substantial	substantial	JJ
cord-294360-1oymweb0	19	11	number	number	NN
cord-294360-1oymweb0	19	12	of	of	IN
cord-294360-1oymweb0	19	13	years	year	NNS
cord-294360-1oymweb0	19	14	of	of	IN
cord-294360-1oymweb0	19	15	life	life	NN
cord-294360-1oymweb0	19	16	lost	lose	VBN
cord-294360-1oymweb0	19	17	,	,	,
cord-294360-1oymweb0	19	18	even	even	RB
cord-294360-1oymweb0	19	19	after	after	IN
cord-294360-1oymweb0	19	20	taking	take	VBG
cord-294360-1oymweb0	19	21	multimorbidity	multimorbidity	NN
cord-294360-1oymweb0	19	22	into	into	IN
cord-294360-1oymweb0	19	23	account	account	NN
cord-294360-1oymweb0	19	24	.	.	.
cord-294360-1oymweb0	20	1	4	4	LS
cord-294360-1oymweb0	21	1	This	this	DT
cord-294360-1oymweb0	21	2	means	mean	VBZ
cord-294360-1oymweb0	21	3	that	that	IN
cord-294360-1oymweb0	21	4	those	those	DT
cord-294360-1oymweb0	21	5	with	with	IN
cord-294360-1oymweb0	21	6	multiple	multiple	JJ
cord-294360-1oymweb0	21	7	LTCs	ltc	NNS
cord-294360-1oymweb0	21	8	who	who	WP
cord-294360-1oymweb0	21	9	died	die	VBD
cord-294360-1oymweb0	21	10	from	from	IN
cord-294360-1oymweb0	21	11	COVID-19	COVID-19	NNP
cord-294360-1oymweb0	21	12	still	still	RB
cord-294360-1oymweb0	21	13	had	have	VBD
cord-294360-1oymweb0	21	14	many	many	JJ
cord-294360-1oymweb0	21	15	years	year	NNS
cord-294360-1oymweb0	21	16	of	of	IN
cord-294360-1oymweb0	21	17	life	life	NN
cord-294360-1oymweb0	21	18	ahead	ahead	RB
cord-294360-1oymweb0	21	19	prior	prior	RB
cord-294360-1oymweb0	21	20	to	to	IN
cord-294360-1oymweb0	21	21	infection	infection	NN
cord-294360-1oymweb0	21	22	.	.	.
cord-294360-1oymweb0	22	1	Thus	thus	RB
cord-294360-1oymweb0	22	2	,	,	,
cord-294360-1oymweb0	22	3	to	to	TO
cord-294360-1oymweb0	22	4	prevent	prevent	VB
cord-294360-1oymweb0	22	5	this	this	DT
cord-294360-1oymweb0	22	6	premature	premature	JJ
cord-294360-1oymweb0	22	7	mortality	mortality	NN
cord-294360-1oymweb0	22	8	,	,	,
cord-294360-1oymweb0	22	9	it	-PRON-	PRP
cord-294360-1oymweb0	22	10	is	be	VBZ
cord-294360-1oymweb0	22	11	imperative	imperative	JJ
cord-294360-1oymweb0	22	12	to	to	TO
cord-294360-1oymweb0	22	13	investigate	investigate	VB
cord-294360-1oymweb0	22	14	the	the	DT
cord-294360-1oymweb0	22	15	risks	risk	NNS
cord-294360-1oymweb0	22	16	posed	pose	VBN
cord-294360-1oymweb0	22	17	by	by	IN
cord-294360-1oymweb0	22	18	COVID-19	COVID-19	NNP
cord-294360-1oymweb0	22	19	for	for	IN
cord-294360-1oymweb0	22	20	those	those	DT
cord-294360-1oymweb0	22	21	with	with	IN
cord-294360-1oymweb0	22	22	multimorbidity	multimorbidity	NN
cord-294360-1oymweb0	22	23	and	and	CC
cord-294360-1oymweb0	22	24	generate	generate	VB
cord-294360-1oymweb0	22	25	evidence	evidence	NN
cord-294360-1oymweb0	22	26	that	that	WDT
cord-294360-1oymweb0	22	27	can	can	MD
cord-294360-1oymweb0	22	28	determine	determine	VB
cord-294360-1oymweb0	22	29	how	how	WRB
cord-294360-1oymweb0	22	30	best	good	JJS
cord-294360-1oymweb0	22	31	to	to	TO
cord-294360-1oymweb0	22	32	stratify	stratify	VB
cord-294360-1oymweb0	22	33	the	the	DT
cord-294360-1oymweb0	22	34	risk	risk	NN
cord-294360-1oymweb0	22	35	for	for	IN
cord-294360-1oymweb0	22	36	people	people	NNS
cord-294360-1oymweb0	22	37	with	with	IN
cord-294360-1oymweb0	22	38	specific	specific	JJ
cord-294360-1oymweb0	22	39	numbers	number	NNS
cord-294360-1oymweb0	22	40	and	and	CC
cord-294360-1oymweb0	22	41	types	type	NNS
cord-294360-1oymweb0	22	42	of	of	IN
cord-294360-1oymweb0	22	43	LTCs	ltc	NNS
cord-294360-1oymweb0	22	44	alongside	alongside	IN
cord-294360-1oymweb0	22	45	their	-PRON-	PRP$
cord-294360-1oymweb0	22	46	sociodemographic	sociodemographic	JJ
cord-294360-1oymweb0	22	47	characteristics	characteristic	NNS
cord-294360-1oymweb0	22	48	.	.	.
cord-294360-1oymweb0	23	1	Such	such	JJ
cord-294360-1oymweb0	23	2	data	data	NN
cord-294360-1oymweb0	23	3	is	be	VBZ
cord-294360-1oymweb0	23	4	crucial	crucial	JJ
cord-294360-1oymweb0	23	5	to	to	TO
cord-294360-1oymweb0	23	6	empower	empower	VB
cord-294360-1oymweb0	23	7	clinicians	clinician	NNS
cord-294360-1oymweb0	23	8	and	and	CC
cord-294360-1oymweb0	23	9	policymakers	policymaker	NNS
cord-294360-1oymweb0	23	10	to	to	TO
cord-294360-1oymweb0	23	11	give	give	VB
cord-294360-1oymweb0	23	12	optimal	optimal	JJ
cord-294360-1oymweb0	23	13	advice	advice	NN
cord-294360-1oymweb0	23	14	to	to	IN
cord-294360-1oymweb0	23	15	those	those	DT
cord-294360-1oymweb0	23	16	with	with	IN
cord-294360-1oymweb0	23	17	differing	differ	VBG
cord-294360-1oymweb0	23	18	patterns	pattern	NNS
cord-294360-1oymweb0	23	19	and	and	CC
cord-294360-1oymweb0	23	20	extents	extent	NNS
cord-294360-1oymweb0	23	21	of	of	IN
cord-294360-1oymweb0	23	22	multimorbidity	multimorbidity	NN
cord-294360-1oymweb0	23	23	and	and	CC
cord-294360-1oymweb0	23	24	to	to	TO
cord-294360-1oymweb0	23	25	reduce	reduce	VB
cord-294360-1oymweb0	23	26	the	the	DT
cord-294360-1oymweb0	23	27	impact	impact	NN
cord-294360-1oymweb0	23	28	of	of	IN
cord-294360-1oymweb0	23	29	COVID-19	COVID-19	NNP
cord-294360-1oymweb0	23	30	that	that	WDT
cord-294360-1oymweb0	23	31	is	be	VBZ
cord-294360-1oymweb0	23	32	mediated	mediate	VBN
cord-294360-1oymweb0	23	33	through	through	IN
cord-294360-1oymweb0	23	34	multimorbidity	multimorbidity	NN
cord-294360-1oymweb0	23	35	.	.	.
cord-294360-1oymweb0	24	1	Some	some	DT
cord-294360-1oymweb0	24	2	early	early	JJ
cord-294360-1oymweb0	24	3	studies	study	NNS
cord-294360-1oymweb0	24	4	have	have	VBP
cord-294360-1oymweb0	24	5	started	start	VBN
cord-294360-1oymweb0	24	6	the	the	DT
cord-294360-1oymweb0	24	7	process	process	NN
cord-294360-1oymweb0	24	8	of	of	IN
cord-294360-1oymweb0	24	9	developing	develop	VBG
cord-294360-1oymweb0	24	10	COVID-19	covid-19	JJ
cord-294360-1oymweb0	24	11	risk	risk	NN
cord-294360-1oymweb0	24	12	stratification	stratification	NN
cord-294360-1oymweb0	24	13	for	for	IN
cord-294360-1oymweb0	24	14	those	those	DT
cord-294360-1oymweb0	24	15	with	with	IN
cord-294360-1oymweb0	24	16	multimorbidity	multimorbidity	NN
cord-294360-1oymweb0	24	17	.	.	.
cord-294360-1oymweb0	25	1	For	for	IN
cord-294360-1oymweb0	25	2	example	example	NN
cord-294360-1oymweb0	25	3	,	,	,
cord-294360-1oymweb0	25	4	emerging	emerge	VBG
cord-294360-1oymweb0	25	5	evidence	evidence	NN
cord-294360-1oymweb0	25	6	indicates	indicate	VBZ
cord-294360-1oymweb0	25	7	that	that	IN
cord-294360-1oymweb0	25	8	both	both	DT
cord-294360-1oymweb0	25	9	multimorbidity	multimorbidity	NN
cord-294360-1oymweb0	25	10	(	(	-LRB-
cord-294360-1oymweb0	25	11	especially	especially	RB
cord-294360-1oymweb0	25	12	cardiometabolic	cardiometabolic	NNP
cord-294360-1oymweb0	25	13	multimorbidity	multimorbidity	NNP
cord-294360-1oymweb0	25	14	)	)	-RRB-
cord-294360-1oymweb0	25	15	and	and	CC
cord-294360-1oymweb0	25	16	polypharmacy	polypharmacy	NNP
cord-294360-1oymweb0	25	17	(	(	-LRB-
cord-294360-1oymweb0	25	18	often	often	RB
cord-294360-1oymweb0	25	19	a	a	DT
cord-294360-1oymweb0	25	20	proxy	proxy	NN
cord-294360-1oymweb0	25	21	for	for	IN
cord-294360-1oymweb0	25	22	multimorbidity	multimorbidity	NNP
cord-294360-1oymweb0	25	23	)	)	-RRB-
cord-294360-1oymweb0	25	24	are	be	VBP
cord-294360-1oymweb0	25	25	associated	associate	VBN
cord-294360-1oymweb0	25	26	with	with	IN
cord-294360-1oymweb0	25	27	a	a	DT
cord-294360-1oymweb0	25	28	higher	high	JJR
cord-294360-1oymweb0	25	29	risk	risk	NN
cord-294360-1oymweb0	25	30	of	of	IN
cord-294360-1oymweb0	25	31	COVID-19	covid-19	JJ
cord-294360-1oymweb0	25	32	infection	infection	NN
cord-294360-1oymweb0	25	33	.	.	.
cord-294360-1oymweb0	26	1	5	5	LS
cord-294360-1oymweb0	27	1	In	in	IN
cord-294360-1oymweb0	27	2	addition	addition	NN
cord-294360-1oymweb0	27	3	,	,	,
cord-294360-1oymweb0	27	4	when	when	WRB
cord-294360-1oymweb0	27	5	factors	factor	NNS
cord-294360-1oymweb0	27	6	known	know	VBN
cord-294360-1oymweb0	27	7	to	to	TO
cord-294360-1oymweb0	27	8	be	be	VB
cord-294360-1oymweb0	27	9	associated	associate	VBN
cord-294360-1oymweb0	27	10	with	with	IN
cord-294360-1oymweb0	27	11	poorer	poor	JJR
cord-294360-1oymweb0	27	12	COVID-19	covid-19	JJ
cord-294360-1oymweb0	27	13	outcomes	outcome	NNS
cord-294360-1oymweb0	27	14	(	(	-LRB-
cord-294360-1oymweb0	27	15	e.g.	e.g.	IN
cord-294360-1oymweb0	27	16	non	non	JJ
cord-294360-1oymweb0	27	17	-	-	JJ
cord-294360-1oymweb0	27	18	white	white	JJ
cord-294360-1oymweb0	27	19	ethnicity	ethnicity	NN
cord-294360-1oymweb0	27	20	,	,	,
cord-294360-1oymweb0	27	21	socioeconomic	socioeconomic	JJ
cord-294360-1oymweb0	27	22	deprivation	deprivation	NN
cord-294360-1oymweb0	27	23	,	,	,
cord-294360-1oymweb0	27	24	and	and	CC
cord-294360-1oymweb0	27	25	obesity	obesity	NN
cord-294360-1oymweb0	27	26	)	)	-RRB-
cord-294360-1oymweb0	27	27	are	be	VBP
cord-294360-1oymweb0	27	28	combined	combine	VBN
cord-294360-1oymweb0	27	29	with	with	IN
cord-294360-1oymweb0	27	30	multimorbidity	multimorbidity	NN
cord-294360-1oymweb0	27	31	,	,	,
cord-294360-1oymweb0	27	32	the	the	DT
cord-294360-1oymweb0	27	33	association	association	NN
cord-294360-1oymweb0	27	34	with	with	IN
cord-294360-1oymweb0	27	35	COVID-19	COVID-19	NNP
cord-294360-1oymweb0	27	36	is	be	VBZ
cord-294360-1oymweb0	27	37	even	even	RB
cord-294360-1oymweb0	27	38	starker	stark	JJR
cord-294360-1oymweb0	27	39	.	.	.
cord-294360-1oymweb0	28	1	5	5	LS
cord-294360-1oymweb0	29	1	While	while	IN
cord-294360-1oymweb0	29	2	much	much	JJ
cord-294360-1oymweb0	29	3	public	public	JJ
cord-294360-1oymweb0	29	4	health	health	NN
cord-294360-1oymweb0	29	5	advice	advice	NN
cord-294360-1oymweb0	29	6	provides	provide	VBZ
cord-294360-1oymweb0	29	7	substantial	substantial	JJ
cord-294360-1oymweb0	29	8	information	information	NN
cord-294360-1oymweb0	29	9	about	about	IN
cord-294360-1oymweb0	29	10	the	the	DT
cord-294360-1oymweb0	29	11	increased	increase	VBN
cord-294360-1oymweb0	29	12	COVID-19	COVID-19	NNP
cord-294360-1oymweb0	29	13	risks	risk	NNS
cord-294360-1oymweb0	29	14	posed	pose	VBN
cord-294360-1oymweb0	29	15	by	by	IN
cord-294360-1oymweb0	29	16	individual	individual	JJ
cord-294360-1oymweb0	29	17	LTCs	ltc	NNS
cord-294360-1oymweb0	29	18	such	such	JJ
cord-294360-1oymweb0	29	19	as	as	IN
cord-294360-1oymweb0	29	20	cancer	cancer	NN
cord-294360-1oymweb0	29	21	or	or	CC
cord-294360-1oymweb0	29	22	cardiovascular	cardiovascular	JJ
cord-294360-1oymweb0	29	23	disease	disease	NN
cord-294360-1oymweb0	30	1	there	there	EX
cord-294360-1oymweb0	30	2	is	be	VBZ
cord-294360-1oymweb0	30	3	a	a	DT
cord-294360-1oymweb0	30	4	glaring	glaring	JJ
cord-294360-1oymweb0	30	5	absence	absence	NN
cord-294360-1oymweb0	30	6	of	of	IN
cord-294360-1oymweb0	30	7	information	information	NN
cord-294360-1oymweb0	30	8	about	about	IN
cord-294360-1oymweb0	30	9	multimorbidity	multimorbidity	NN
cord-294360-1oymweb0	30	10	.	.	.
cord-294360-1oymweb0	31	1	Public	public	JJ
cord-294360-1oymweb0	31	2	health	health	NN
cord-294360-1oymweb0	31	3	resources	resource	NNS
cord-294360-1oymweb0	31	4	,	,	,
cord-294360-1oymweb0	31	5	such	such	JJ
cord-294360-1oymweb0	31	6	as	as	IN
cord-294360-1oymweb0	31	7	those	those	DT
cord-294360-1oymweb0	31	8	from	from	IN
cord-294360-1oymweb0	31	9	the	the	DT
cord-294360-1oymweb0	31	10	Centers	Centers	NNPS
cord-294360-1oymweb0	31	11	for	for	IN
cord-294360-1oymweb0	31	12	Disease	Disease	NNP
cord-294360-1oymweb0	31	13	Control	Control	NNP
cord-294360-1oymweb0	31	14	and	and	CC
cord-294360-1oymweb0	31	15	Prevention	Prevention	NNP
cord-294360-1oymweb0	31	16	(	(	-LRB-
cord-294360-1oymweb0	31	17	USA	USA	NNP
cord-294360-1oymweb0	31	18	)	)	-RRB-
cord-294360-1oymweb0	31	19	,	,	,
cord-294360-1oymweb0	31	20	do	do	VBP
cord-294360-1oymweb0	31	21	not	not	RB
cord-294360-1oymweb0	31	22	highlight	highlight	VB
cord-294360-1oymweb0	31	23	the	the	DT
cord-294360-1oymweb0	31	24	higher	high	JJR
cord-294360-1oymweb0	31	25	risks	risk	NNS
cord-294360-1oymweb0	31	26	of	of	IN
cord-294360-1oymweb0	31	27	COVID-19	covid-19	CD
cord-294360-1oymweb0	31	28	for	for	IN
cord-294360-1oymweb0	31	29	people	people	NNS
cord-294360-1oymweb0	31	30	with	with	IN
cord-294360-1oymweb0	31	31	multimorbidity	multimorbidity	NN
cord-294360-1oymweb0	31	32	,	,	,
cord-294360-1oymweb0	31	33	despite	despite	IN
cord-294360-1oymweb0	31	34	the	the	DT
cord-294360-1oymweb0	31	35	evidence	evidence	NN
cord-294360-1oymweb0	31	36	highlighted	highlight	VBN
cord-294360-1oymweb0	31	37	here	here	RB
cord-294360-1oymweb0	31	38	.	.	.
cord-294360-1oymweb0	32	1	While	while	IN
cord-294360-1oymweb0	32	2	there	there	EX
cord-294360-1oymweb0	32	3	are	be	VBP
cord-294360-1oymweb0	32	4	many	many	JJ
cord-294360-1oymweb0	32	5	patient	patient	JJ
cord-294360-1oymweb0	32	6	representative	representative	NN
cord-294360-1oymweb0	32	7	organisations	organisation	NNS
cord-294360-1oymweb0	32	8	for	for	IN
cord-294360-1oymweb0	32	9	specific	specific	JJ
cord-294360-1oymweb0	32	10	conditions	condition	NNS
cord-294360-1oymweb0	32	11	such	such	JJ
cord-294360-1oymweb0	32	12	as	as	IN
cord-294360-1oymweb0	32	13	Asthma	Asthma	NNP
cord-294360-1oymweb0	32	14	UK	UK	NNP
cord-294360-1oymweb0	32	15	,	,	,
cord-294360-1oymweb0	32	16	the	the	DT
cord-294360-1oymweb0	32	17	American	American	NNP
cord-294360-1oymweb0	32	18	Heart	Heart	NNP
cord-294360-1oymweb0	32	19	Association	Association	NNP
cord-294360-1oymweb0	32	20	,	,	,
cord-294360-1oymweb0	32	21	and	and	CC
cord-294360-1oymweb0	32	22	the	the	DT
cord-294360-1oymweb0	32	23	European	European	NNP
cord-294360-1oymweb0	32	24	Cancer	Cancer	NNP
cord-294360-1oymweb0	32	25	Patient	Patient	NNP
cord-294360-1oymweb0	32	26	Coalition	Coalition	NNP
cord-294360-1oymweb0	32	27	,	,	,
cord-294360-1oymweb0	32	28	organisations	organisation	NNS
cord-294360-1oymweb0	32	29	that	that	WDT
cord-294360-1oymweb0	32	30	focus	focus	VBP
cord-294360-1oymweb0	32	31	on	on	IN
cord-294360-1oymweb0	32	32	chronic	chronic	JJ
cord-294360-1oymweb0	32	33	illness	illness	NN
cord-294360-1oymweb0	32	34	in	in	IN
cord-294360-1oymweb0	32	35	general	general	JJ
cord-294360-1oymweb0	32	36	are	be	VBP
cord-294360-1oymweb0	32	37	rare	rare	JJ
cord-294360-1oymweb0	32	38	and	and	CC
cord-294360-1oymweb0	32	39	fewer	few	JJR
cord-294360-1oymweb0	32	40	,	,	,
cord-294360-1oymweb0	32	41	if	if	IN
cord-294360-1oymweb0	32	42	any	any	DT
cord-294360-1oymweb0	32	43	,	,	,
cord-294360-1oymweb0	32	44	target	target	VB
cord-294360-1oymweb0	32	45	multimorbidity	multimorbidity	NN
cord-294360-1oymweb0	32	46	.	.	.
cord-294360-1oymweb0	33	1	Such	such	JJ
cord-294360-1oymweb0	33	2	organisations	organisation	NNS
cord-294360-1oymweb0	33	3	are	be	VBP
cord-294360-1oymweb0	33	4	a	a	DT
cord-294360-1oymweb0	33	5	vital	vital	JJ
cord-294360-1oymweb0	33	6	and	and	CC
cord-294360-1oymweb0	33	7	trusted	trusted	JJ
cord-294360-1oymweb0	33	8	source	source	NN
cord-294360-1oymweb0	33	9	of	of	IN
cord-294360-1oymweb0	33	10	information	information	NN
cord-294360-1oymweb0	33	11	and	and	CC
cord-294360-1oymweb0	33	12	support	support	NN
cord-294360-1oymweb0	33	13	for	for	IN
cord-294360-1oymweb0	33	14	patients	patient	NNS
cord-294360-1oymweb0	33	15	,	,	,
cord-294360-1oymweb0	33	16	carers	carer	NNS
cord-294360-1oymweb0	33	17	,	,	,
cord-294360-1oymweb0	33	18	and	and	CC
cord-294360-1oymweb0	33	19	the	the	DT
cord-294360-1oymweb0	33	20	public	public	NN
cord-294360-1oymweb0	33	21	and	and	CC
cord-294360-1oymweb0	33	22	provide	provide	VB
cord-294360-1oymweb0	33	23	ample	ample	JJ
cord-294360-1oymweb0	33	24	advice	advice	NN
cord-294360-1oymweb0	33	25	and	and	CC
cord-294360-1oymweb0	33	26	information	information	NN
cord-294360-1oymweb0	33	27	about	about	IN
cord-294360-1oymweb0	33	28	the	the	DT
cord-294360-1oymweb0	33	29	risks	risk	NNS
cord-294360-1oymweb0	33	30	of	of	IN
cord-294360-1oymweb0	33	31	COVID-19	covid-19	CD
cord-294360-1oymweb0	33	32	to	to	IN
cord-294360-1oymweb0	33	33	individuals	individual	NNS
cord-294360-1oymweb0	33	34	with	with	IN
cord-294360-1oymweb0	33	35	specific	specific	JJ
cord-294360-1oymweb0	33	36	LTCs	ltc	NNS
cord-294360-1oymweb0	33	37	.	.	.
cord-294360-1oymweb0	34	1	In	in	IN
cord-294360-1oymweb0	34	2	contrast	contrast	NN
cord-294360-1oymweb0	34	3	,	,	,
cord-294360-1oymweb0	34	4	those	those	DT
cord-294360-1oymweb0	34	5	with	with	IN
cord-294360-1oymweb0	34	6	1	1	CD
cord-294360-1oymweb0	34	7	Institute	Institute	NNP
cord-294360-1oymweb0	34	8	of	of	IN
cord-294360-1oymweb0	34	9	Health	Health	NNP
cord-294360-1oymweb0	34	10	and	and	CC
cord-294360-1oymweb0	34	11	Wellbeing	Wellbeing	NNP
cord-294360-1oymweb0	34	12	,	,	,
cord-294360-1oymweb0	34	13	University	University	NNP
cord-294360-1oymweb0	34	14	of	of	IN
cord-294360-1oymweb0	34	15	Glasgow	Glasgow	NNP
cord-294360-1oymweb0	34	16	,	,	,
cord-294360-1oymweb0	34	17	Glasgow	Glasgow	NNP
cord-294360-1oymweb0	34	18	,	,	,
cord-294360-1oymweb0	34	19	UK	UK	NNP
cord-294360-1oymweb0	34	20	multimorbidity	multimorbidity	NN
cord-294360-1oymweb0	34	21	remain	remain	VBP
cord-294360-1oymweb0	34	22	largely	largely	RB
cord-294360-1oymweb0	34	23	forgotten	forget	VBN
cord-294360-1oymweb0	34	24	and	and	CC
cord-294360-1oymweb0	34	25	disadvantaged	disadvantage	VBN
cord-294360-1oymweb0	34	26	through	through	IN
cord-294360-1oymweb0	34	27	the	the	DT
cord-294360-1oymweb0	34	28	scarcity	scarcity	NN
cord-294360-1oymweb0	34	29	of	of	IN
cord-294360-1oymweb0	34	30	organisations	organisation	NNS
cord-294360-1oymweb0	34	31	that	that	WDT
cord-294360-1oymweb0	34	32	advocate	advocate	VBP
cord-294360-1oymweb0	34	33	specifically	specifically	RB
cord-294360-1oymweb0	34	34	for	for	IN
cord-294360-1oymweb0	34	35	those	those	DT
cord-294360-1oymweb0	34	36	with	with	IN
cord-294360-1oymweb0	34	37	multiple	multiple	JJ
cord-294360-1oymweb0	34	38	LTCs	ltc	NNS
cord-294360-1oymweb0	34	39	and	and	CC
cord-294360-1oymweb0	34	40	via	via	IN
cord-294360-1oymweb0	34	41	the	the	DT
cord-294360-1oymweb0	34	42	absence	absence	NN
cord-294360-1oymweb0	34	43	of	of	IN
cord-294360-1oymweb0	34	44	information	information	NN
cord-294360-1oymweb0	34	45	tailored	tailor	VBN
cord-294360-1oymweb0	34	46	to	to	IN
cord-294360-1oymweb0	34	47	their	-PRON-	PRP$
cord-294360-1oymweb0	34	48	complex	complex	JJ
cord-294360-1oymweb0	34	49	needs	need	NNS
cord-294360-1oymweb0	34	50	.	.	.
cord-294360-1oymweb0	35	1	This	this	DT
cord-294360-1oymweb0	35	2	dearth	dearth	NN
cord-294360-1oymweb0	35	3	of	of	IN
cord-294360-1oymweb0	35	4	information	information	NN
cord-294360-1oymweb0	35	5	and	and	CC
cord-294360-1oymweb0	35	6	support	support	NN
cord-294360-1oymweb0	35	7	also	also	RB
cord-294360-1oymweb0	35	8	means	mean	VBZ
cord-294360-1oymweb0	35	9	employers	employer	NNS
cord-294360-1oymweb0	35	10	are	be	VBP
cord-294360-1oymweb0	35	11	less	less	RBR
cord-294360-1oymweb0	35	12	aware	aware	JJ
cord-294360-1oymweb0	35	13	of	of	IN
cord-294360-1oymweb0	35	14	the	the	DT
cord-294360-1oymweb0	35	15	risks	risk	NNS
cord-294360-1oymweb0	35	16	faced	face	VBN
cord-294360-1oymweb0	35	17	by	by	IN
cord-294360-1oymweb0	35	18	their	-PRON-	PRP$
cord-294360-1oymweb0	35	19	employees	employee	NNS
cord-294360-1oymweb0	35	20	with	with	IN
cord-294360-1oymweb0	35	21	multimorbidity	multimorbidity	NN
cord-294360-1oymweb0	35	22	.	.	.
cord-294360-1oymweb0	36	1	Organisations	organisation	NNS
cord-294360-1oymweb0	36	2	are	be	VBP
cord-294360-1oymweb0	36	3	therefore	therefore	RB
cord-294360-1oymweb0	36	4	less	less	RBR
cord-294360-1oymweb0	36	5	likely	likely	JJ
cord-294360-1oymweb0	36	6	to	to	TO
cord-294360-1oymweb0	36	7	make	make	VB
cord-294360-1oymweb0	36	8	workplace	workplace	NN
cord-294360-1oymweb0	36	9	adaptations	adaptation	NNS
cord-294360-1oymweb0	36	10	that	that	WDT
cord-294360-1oymweb0	36	11	they	-PRON-	PRP
cord-294360-1oymweb0	36	12	might	may	MD
cord-294360-1oymweb0	36	13	do	do	VB
cord-294360-1oymweb0	36	14	for	for	IN
cord-294360-1oymweb0	36	15	those	those	DT
cord-294360-1oymweb0	36	16	affected	affect	VBN
cord-294360-1oymweb0	36	17	with	with	IN
cord-294360-1oymweb0	36	18	single	single	JJ
cord-294360-1oymweb0	36	19	LTCs	ltc	NNS
cord-294360-1oymweb0	36	20	.	.	.
cord-294360-1oymweb0	37	1	Equally	equally	RB
cord-294360-1oymweb0	37	2	,	,	,
cord-294360-1oymweb0	37	3	people	people	NNS
cord-294360-1oymweb0	37	4	living	live	VBG
cord-294360-1oymweb0	37	5	with	with	IN
cord-294360-1oymweb0	37	6	multimorbidity	multimorbidity	NN
cord-294360-1oymweb0	37	7	may	may	MD
cord-294360-1oymweb0	37	8	be	be	VB
cord-294360-1oymweb0	37	9	unaware	unaware	JJ
cord-294360-1oymweb0	37	10	of	of	IN
cord-294360-1oymweb0	37	11	the	the	DT
cord-294360-1oymweb0	37	12	additional	additional	JJ
cord-294360-1oymweb0	37	13	COVID-19	covid-19	JJ
cord-294360-1oymweb0	37	14	risks	risk	NNS
cord-294360-1oymweb0	37	15	associated	associate	VBN
cord-294360-1oymweb0	37	16	with	with	IN
cord-294360-1oymweb0	37	17	having	have	VBG
cord-294360-1oymweb0	37	18	a	a	DT
cord-294360-1oymweb0	37	19	combination	combination	NN
cord-294360-1oymweb0	37	20	of	of	IN
cord-294360-1oymweb0	37	21	multiple	multiple	JJ
cord-294360-1oymweb0	37	22	LTCs	ltc	NNS
cord-294360-1oymweb0	37	23	as	as	IN
cord-294360-1oymweb0	37	24	opposed	oppose	VBN
cord-294360-1oymweb0	37	25	to	to	IN
cord-294360-1oymweb0	37	26	just	just	RB
cord-294360-1oymweb0	37	27	one	one	CD
cord-294360-1oymweb0	37	28	.	.	.
cord-294360-1oymweb0	38	1	These	these	DT
cord-294360-1oymweb0	38	2	issues	issue	NNS
cord-294360-1oymweb0	38	3	are	be	VBP
cord-294360-1oymweb0	38	4	particularly	particularly	RB
cord-294360-1oymweb0	38	5	important	important	JJ
cord-294360-1oymweb0	38	6	for	for	IN
cord-294360-1oymweb0	38	7	those	those	DT
cord-294360-1oymweb0	38	8	already	already	RB
cord-294360-1oymweb0	38	9	identified	identify	VBN
cord-294360-1oymweb0	38	10	as	as	IN
cord-294360-1oymweb0	38	11	being	be	VBG
cord-294360-1oymweb0	38	12	at	at	IN
cord-294360-1oymweb0	38	13	higher	high	JJR
cord-294360-1oymweb0	38	14	risk	risk	NN
cord-294360-1oymweb0	38	15	,	,	,
cord-294360-1oymweb0	38	16	for	for	IN
cord-294360-1oymweb0	38	17	example	example	NN
cord-294360-1oymweb0	38	18	,	,	,
cord-294360-1oymweb0	38	19	those	those	DT
cord-294360-1oymweb0	38	20	of	of	IN
cord-294360-1oymweb0	38	21	non	non	JJ
cord-294360-1oymweb0	38	22	-	-	JJ
cord-294360-1oymweb0	38	23	white	white	JJ
cord-294360-1oymweb0	38	24	ethnicity	ethnicity	NN
cord-294360-1oymweb0	38	25	.	.	.
cord-294360-1oymweb0	39	1	Here	here	RB
cord-294360-1oymweb0	39	2	the	the	DT
cord-294360-1oymweb0	39	3	gaps	gap	NNS
cord-294360-1oymweb0	39	4	in	in	IN
cord-294360-1oymweb0	39	5	research	research	NN
cord-294360-1oymweb0	39	6	,	,	,
cord-294360-1oymweb0	39	7	policy	policy	NN
cord-294360-1oymweb0	39	8	,	,	,
cord-294360-1oymweb0	39	9	and	and	CC
cord-294360-1oymweb0	39	10	practice	practice	NN
cord-294360-1oymweb0	39	11	relating	relate	VBG
cord-294360-1oymweb0	39	12	to	to	IN
cord-294360-1oymweb0	39	13	multimorbidity	multimorbidity	NNP
cord-294360-1oymweb0	39	14	and	and	CC
cord-294360-1oymweb0	39	15	COVID-19	COVID-19	NNP
cord-294360-1oymweb0	39	16	are	be	VBP
cord-294360-1oymweb0	39	17	laid	lay	VBN
cord-294360-1oymweb0	39	18	bare	bare	JJ
cord-294360-1oymweb0	39	19	.	.	.
cord-294360-1oymweb0	40	1	Although	although	IN
cord-294360-1oymweb0	40	2	these	these	DT
cord-294360-1oymweb0	40	3	gaps	gap	NNS
cord-294360-1oymweb0	40	4	potentially	potentially	RB
cord-294360-1oymweb0	40	5	represent	represent	VBP
cord-294360-1oymweb0	40	6	shortcomings	shortcoming	NNS
cord-294360-1oymweb0	40	7	of	of	IN
cord-294360-1oymweb0	40	8	research	research	NN
cord-294360-1oymweb0	40	9	funders	funder	NNS
cord-294360-1oymweb0	40	10	and	and	CC
cord-294360-1oymweb0	40	11	the	the	DT
cord-294360-1oymweb0	40	12	wider	wide	JJR
cord-294360-1oymweb0	40	13	public	public	JJ
cord-294360-1oymweb0	40	14	health	health	NN
cord-294360-1oymweb0	40	15	and	and	CC
cord-294360-1oymweb0	40	16	health	health	NN
cord-294360-1oymweb0	40	17	practitioner	practitioner	NN
cord-294360-1oymweb0	40	18	community	community	NN
cord-294360-1oymweb0	40	19	,	,	,
cord-294360-1oymweb0	40	20	they	-PRON-	PRP
cord-294360-1oymweb0	40	21	also	also	RB
cord-294360-1oymweb0	40	22	represent	represent	VBP
cord-294360-1oymweb0	40	23	opportunities	opportunity	NNS
cord-294360-1oymweb0	40	24	for	for	IN
cord-294360-1oymweb0	40	25	us	-PRON-	PRP
cord-294360-1oymweb0	40	26	all	all	DT
cord-294360-1oymweb0	40	27	to	to	TO
cord-294360-1oymweb0	40	28	do	do	VB
cord-294360-1oymweb0	40	29	more	more	JJR
cord-294360-1oymweb0	40	30	to	to	TO
cord-294360-1oymweb0	40	31	protect	protect	VB
cord-294360-1oymweb0	40	32	those	those	DT
cord-294360-1oymweb0	40	33	most	most	RBS
cord-294360-1oymweb0	40	34	vulnerable	vulnerable	JJ
cord-294360-1oymweb0	40	35	to	to	IN
cord-294360-1oymweb0	40	36	COVID-19	COVID-19	NNP
cord-294360-1oymweb0	40	37	.	.	.
cord-294360-1oymweb0	41	1	Consequently	consequently	RB
cord-294360-1oymweb0	41	2	,	,	,
cord-294360-1oymweb0	41	3	as	as	IN
cord-294360-1oymweb0	41	4	part	part	NN
cord-294360-1oymweb0	41	5	of	of	IN
cord-294360-1oymweb0	41	6	this	this	DT
cord-294360-1oymweb0	41	7	appeal	appeal	NN
cord-294360-1oymweb0	41	8	for	for	IN
cord-294360-1oymweb0	41	9	urgent	urgent	JJ
cord-294360-1oymweb0	41	10	action	action	NN
cord-294360-1oymweb0	41	11	on	on	IN
cord-294360-1oymweb0	41	12	multimorbidity	multimorbidity	NN
cord-294360-1oymweb0	41	13	and	and	CC
cord-294360-1oymweb0	41	14	to	to	TO
cord-294360-1oymweb0	41	15	mitigate	mitigate	VB
cord-294360-1oymweb0	41	16	the	the	DT
cord-294360-1oymweb0	41	17	devastating	devastating	JJ
cord-294360-1oymweb0	41	18	impact	impact	NN
cord-294360-1oymweb0	41	19	of	of	IN
cord-294360-1oymweb0	41	20	COVID-19	COVID-19	NNP
cord-294360-1oymweb0	41	21	,	,	,
cord-294360-1oymweb0	41	22	we	-PRON-	PRP
cord-294360-1oymweb0	41	23	make	make	VBP
cord-294360-1oymweb0	41	24	the	the	DT
cord-294360-1oymweb0	41	25	following	follow	VBG
cord-294360-1oymweb0	41	26	recommendations	recommendation	NNS
cord-294360-1oymweb0	41	27	:	:	:
cord-294360-1oymweb0	41	28	1	1	CD
cord-294360-1oymweb0	41	29	.	.	.
cord-294360-1oymweb0	42	1	Research	research	NN
cord-294360-1oymweb0	42	2	funders	funder	NNS
cord-294360-1oymweb0	42	3	must	must	MD
cord-294360-1oymweb0	42	4	call	call	VB
cord-294360-1oymweb0	42	5	for	for	IN
cord-294360-1oymweb0	42	6	COVID-19	COVID-19	NNP
cord-294360-1oymweb0	42	7	research	research	NN
cord-294360-1oymweb0	42	8	with	with	IN
cord-294360-1oymweb0	42	9	a	a	DT
cord-294360-1oymweb0	42	10	multimorbidity	multimorbidity	NN
cord-294360-1oymweb0	42	11	focus	focus	NN
cord-294360-1oymweb0	42	12	.	.	.
cord-294360-1oymweb0	43	1	2	2	LS
cord-294360-1oymweb0	43	2	.	.	.
cord-294360-1oymweb0	44	1	Public	public	JJ
cord-294360-1oymweb0	44	2	health	health	NN
cord-294360-1oymweb0	44	3	and	and	CC
cord-294360-1oymweb0	44	4	policy	policy	NN
cord-294360-1oymweb0	44	5	advice	advice	NN
cord-294360-1oymweb0	44	6	that	that	WDT
cord-294360-1oymweb0	44	7	defines	define	VBZ
cord-294360-1oymweb0	44	8	and	and	CC
cord-294360-1oymweb0	44	9	classifies	classify	VBZ
cord-294360-1oymweb0	44	10	who	who	WP
cord-294360-1oymweb0	44	11	is	be	VBZ
cord-294360-1oymweb0	44	12	at	at	IN
cord-294360-1oymweb0	44	13	high	high	JJ
cord-294360-1oymweb0	44	14	risk	risk	NN
cord-294360-1oymweb0	44	15	of	of	IN
cord-294360-1oymweb0	44	16	COVID-19	COVID-19	NNP
cord-294360-1oymweb0	44	17	needs	need	NNS
cord-294360-1oymweb0	44	18	to	to	TO
cord-294360-1oymweb0	44	19	highlight	highlight	VB
cord-294360-1oymweb0	44	20	the	the	DT
cord-294360-1oymweb0	44	21	increased	increase	VBN
cord-294360-1oymweb0	44	22	risks	risk	NNS
cord-294360-1oymweb0	44	23	for	for	IN
cord-294360-1oymweb0	44	24	those	those	DT
cord-294360-1oymweb0	44	25	living	live	VBG
cord-294360-1oymweb0	44	26	with	with	IN
cord-294360-1oymweb0	44	27	multimorbidity	multimorbidity	NN
cord-294360-1oymweb0	44	28	.	.	.
cord-294360-1oymweb0	45	1	3	3	LS
cord-294360-1oymweb0	45	2	.	.	.
cord-294360-1oymweb0	46	1	Occupational	occupational	JJ
cord-294360-1oymweb0	46	2	health	health	NN
cord-294360-1oymweb0	46	3	advice	advice	NN
cord-294360-1oymweb0	46	4	must	must	MD
cord-294360-1oymweb0	46	5	include	include	VB
cord-294360-1oymweb0	46	6	and	and	CC
cord-294360-1oymweb0	46	7	communicate	communicate	VB
cord-294360-1oymweb0	46	8	the	the	DT
cord-294360-1oymweb0	46	9	additional	additional	JJ
cord-294360-1oymweb0	46	10	risks	risk	NNS
cord-294360-1oymweb0	46	11	and	and	CC
cord-294360-1oymweb0	46	12	precautions	precaution	NNS
cord-294360-1oymweb0	46	13	for	for	IN
cord-294360-1oymweb0	46	14	individuals	individual	NNS
cord-294360-1oymweb0	46	15	with	with	IN
cord-294360-1oymweb0	46	16	multimorbidity	multimorbidity	NN
cord-294360-1oymweb0	46	17	,	,	,
cord-294360-1oymweb0	46	18	especially	especially	RB
cord-294360-1oymweb0	46	19	for	for	IN
cord-294360-1oymweb0	46	20	those	those	DT
cord-294360-1oymweb0	46	21	already	already	RB
cord-294360-1oymweb0	46	22	known	know	VBN
cord-294360-1oymweb0	46	23	to	to	TO
cord-294360-1oymweb0	46	24	be	be	VB
cord-294360-1oymweb0	46	25	at	at	IN
cord-294360-1oymweb0	46	26	heightened	heightened	JJ
cord-294360-1oymweb0	46	27	risk	risk	NN
cord-294360-1oymweb0	46	28	.	.	.
cord-294360-1oymweb0	47	1	4	4	LS
cord-294360-1oymweb0	47	2	.	.	.
cord-294360-1oymweb0	48	1	Clinical	clinical	JJ
cord-294360-1oymweb0	48	2	guidelines	guideline	NNS
cord-294360-1oymweb0	48	3	need	need	VBP
cord-294360-1oymweb0	48	4	to	to	TO
cord-294360-1oymweb0	48	5	incorporate	incorporate	VB
cord-294360-1oymweb0	48	6	the	the	DT
cord-294360-1oymweb0	48	7	increased	increase	VBN
cord-294360-1oymweb0	48	8	risk	risk	NN
cord-294360-1oymweb0	48	9	posed	pose	VBN
cord-294360-1oymweb0	48	10	by	by	IN
cord-294360-1oymweb0	48	11	multimorbidity	multimorbidity	NN
cord-294360-1oymweb0	48	12	and	and	CC
cord-294360-1oymweb0	48	13	specific	specific	JJ
cord-294360-1oymweb0	48	14	LTC	LTC	NNP
cord-294360-1oymweb0	48	15	combinations	combination	NNS
cord-294360-1oymweb0	48	16	.	.	.
cord-294360-1oymweb0	49	1	The	the	DT
cord-294360-1oymweb0	49	2	Journal	Journal	NNP
cord-294360-1oymweb0	49	3	of	of	IN
cord-294360-1oymweb0	49	4	Comorbidity	Comorbidity	NNP
cord-294360-1oymweb0	49	5	recognises	recognise	VBZ
cord-294360-1oymweb0	49	6	the	the	DT
cord-294360-1oymweb0	49	7	importance	importance	NN
cord-294360-1oymweb0	49	8	of	of	IN
cord-294360-1oymweb0	49	9	understanding	understand	VBG
cord-294360-1oymweb0	49	10	more	more	RBR
cord-294360-1oymweb0	49	11	about	about	IN
cord-294360-1oymweb0	49	12	multimorbidity	multimorbidity	NNP
cord-294360-1oymweb0	49	13	and	and	CC
cord-294360-1oymweb0	49	14	COVID-19	COVID-19	NNP
cord-294360-1oymweb0	49	15	,	,	,
cord-294360-1oymweb0	49	16	and	and	CC
cord-294360-1oymweb0	49	17	now	now	RB
cord-294360-1oymweb0	49	18	has	have	VBZ
cord-294360-1oymweb0	49	19	a	a	DT
cord-294360-1oymweb0	49	20	special	special	JJ
cord-294360-1oymweb0	49	21	call	call	NN
cord-294360-1oymweb0	49	22	for	for	IN
cord-294360-1oymweb0	49	23	papers	paper	NNS
cord-294360-1oymweb0	49	24	which	which	WDT
cord-294360-1oymweb0	49	25	can	can	MD
cord-294360-1oymweb0	49	26	be	be	VB
cord-294360-1oymweb0	49	27	found	find	VBN
cord-294360-1oymweb0	49	28	here	here	RB
cord-294360-1oymweb0	49	29	:	:	:
cord-294360-1oymweb0	49	30	https://journals.sagepub.com/page/cob/call-for-papers/spe	https://journals.sagepub.com/page/cob/call-for-papers/spe	DT
cord-294360-1oymweb0	49	31	cial	cial	JJ
cord-294360-1oymweb0	49	32	-	-	HYPH
cord-294360-1oymweb0	49	33	topics	topic	NNS
cord-294360-1oymweb0	49	34	/	/	SYM
cord-294360-1oymweb0	49	35	multimorbidity	multimorbidity	NN
cord-294360-1oymweb0	49	36	-	-	HYPH
cord-294360-1oymweb0	49	37	or	or	CC
cord-294360-1oymweb0	49	38	-	-	HYPH
cord-294360-1oymweb0	49	39	comorbidity	comorbidity	NN
cord-294360-1oymweb0	49	40	-	-	:
cord-294360-1oymweb0	49	41	and	and	CC
cord-294360-1oymweb0	50	1	-covid-19	-covid-19	NNP
cord-294360-1oymweb0	50	2	.	.	.
cord-294360-1oymweb0	51	1	Frances	Frances	NNP
cord-294360-1oymweb0	51	2	S	S	NNP
cord-294360-1oymweb0	51	3	Mair	Mair	NNP
cord-294360-1oymweb0	52	1	https://orcid.org/0000-0001-9780-1135	https://orcid.org/0000-0001-9780-1135	NNS
cord-294360-1oymweb0	52	2	Factors	factor	NNS
cord-294360-1oymweb0	52	3	associated	associate	VBN
cord-294360-1oymweb0	52	4	with	with	IN
cord-294360-1oymweb0	52	5	COVID-19-related	covid-19-related	JJ
cord-294360-1oymweb0	52	6	death	death	NN
cord-294360-1oymweb0	52	7	using	use	VBG
cord-294360-1oymweb0	52	8	OpenSAFELY	OpenSAFELY	NNP
cord-294360-1oymweb0	52	9	Age	Age	NNP
cord-294360-1oymweb0	52	10	and	and	CC
cord-294360-1oymweb0	52	11	multimorbidity	multimorbidity	NN
cord-294360-1oymweb0	52	12	predict	predict	VBP
cord-294360-1oymweb0	52	13	death	death	NN
cord-294360-1oymweb0	52	14	among	among	IN
cord-294360-1oymweb0	52	15	COVID-19	COVID-19	NNP
cord-294360-1oymweb0	52	16	patients	patient	NNS
cord-294360-1oymweb0	52	17	results	result	NNS
cord-294360-1oymweb0	52	18	of	of	IN
cord-294360-1oymweb0	52	19	the	the	DT
cord-294360-1oymweb0	52	20	SARS	SARS	NNP
cord-294360-1oymweb0	52	21	-	-	HYPH
cord-294360-1oymweb0	52	22	RAS	RAS	NNP
cord-294360-1oymweb0	52	23	study	study	NN
cord-294360-1oymweb0	52	24	of	of	IN
cord-294360-1oymweb0	52	25	the	the	DT
cord-294360-1oymweb0	52	26	Italian	Italian	NNP
cord-294360-1oymweb0	52	27	Society	Society	NNP
cord-294360-1oymweb0	52	28	of	of	IN
cord-294360-1oymweb0	52	29	Hypertension	Hypertension	NNP
cord-294360-1oymweb0	53	1	COVID-19	covid-19	JJ
cord-294360-1oymweb0	53	2	-exploring	-exploring	NNP
cord-294360-1oymweb0	54	1	the	the	DT
cord-294360-1oymweb0	54	2	implications	implication	NNS
cord-294360-1oymweb0	54	3	of	of	IN
cord-294360-1oymweb0	54	4	long	long	JJ
cord-294360-1oymweb0	54	5	-	-	HYPH
cord-294360-1oymweb0	54	6	term	term	NN
cord-294360-1oymweb0	54	7	condition	condition	NN
cord-294360-1oymweb0	54	8	type	type	NN
cord-294360-1oymweb0	54	9	and	and	CC
cord-294360-1oymweb0	54	10	extent	extent	NN
cord-294360-1oymweb0	54	11	of	of	IN
cord-294360-1oymweb0	54	12	multimorbidity	multimorbidity	NN
cord-294360-1oymweb0	54	13	on	on	IN
cord-294360-1oymweb0	54	14	years	year	NNS
cord-294360-1oymweb0	54	15	of	of	IN
cord-294360-1oymweb0	54	16	life	life	NN
cord-294360-1oymweb0	54	17	lost	lose	VBD
cord-294360-1oymweb0	54	18	:	:	:
cord-294360-1oymweb0	54	19	a	a	DT
cord-294360-1oymweb0	54	20	modelling	modelling	NN
cord-294360-1oymweb0	54	21	study	study	NN
cord-294360-1oymweb0	54	22	polypharmacy	polypharmacy	NN
cord-294360-1oymweb0	54	23	,	,	,
cord-294360-1oymweb0	54	24	and	and	CC
cord-294360-1oymweb0	54	25	COVID-19	covid-19	JJ
cord-294360-1oymweb0	54	26	infection	infection	NN
cord-294360-1oymweb0	54	27	within	within	IN
cord-294360-1oymweb0	54	28	the	the	DT
cord-294360-1oymweb0	54	29	UK	UK	NNP
cord-294360-1oymweb0	54	30	Biobank	Biobank	NNP
cord-294360-1oymweb0	54	31	cohort	cohort	NN